FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

87711000001100: Mysoline 250mg tablets (Acorus Therapeutics Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17186101000001112 Mysoline 250mg tablets (Acorus Therapeutics Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
72640001000001114 Mysoline 250mg tablets (SERB) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Is a Product containing precisely primidone 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Has active ingredient Primidone false Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Is a Mysoline true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Has specific active ingredient Primidone true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mysoline 250mg tablets (Acorus Therapeutics Ltd) 100 tablet Is pack of False Mysoline 250mg tablets (Acorus Therapeutics Ltd) Inferred relationship Existential restriction modifier
Mysoline 250mg tablets (Acorus Therapeutics Ltd) 100 tablet Has AMP True Mysoline 250mg tablets (Acorus Therapeutics Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start